CURI vs MPU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

CURI

45.4
AI Score
VS
CURI Wins

MPU

44.6
AI Score

Investment Advisor Scores

CURI

45score
Recommendation
HOLD

MPU

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI MPU Winner
Forward P/E 22.1729 3.9463 MPU
PEG Ratio 0 0 Tie
Revenue Growth 0.5% -49.2% CURI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.4/100 44.6/100 CURI
Profit Margin -11.3% -131.4% CURI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CURI 1M: -9.6% · 3M: -19.7% MPU 1M: -25.4% · 3M: -59.2%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $2.55

MPU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.0%), weak momentum, RSI 41

RSI (14): 41.0 · Price: $0.24

Fundamentals Snapshot

Metric CURI MPU
Market Cap
Forward P/E 10.5 3.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.5%
Gross Margin 0.6% 0.6%
Operating Margin -0.1% -3.8%
EPS -0.14 -0.75
Dividend Yield 0.13%

Frequently Asked Questions

Based on our detailed analysis, CURI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.